Research
Association With AIDS-Related Protocols
- Co-Investigator in phase 3 clinical trials for 3TC and D4T
- Principal Investigator in Serono Study #7623: An open-label, multicenter study to provide expanded access to and to obtain additional safety data on Serostim (mammalian cell derived recombinant human growth hormone, rhGH[m]) in the treatment of adults with advanced AIDS wasting
- Co-Investigator in Expanded Access Program for Viracept, Indini%-ir, and Inverse (Protease Inhibitors)
- Co-Investigator in phase 3 trials for Albendazole, a new approved treatment for microsporidosis
- Co-Investigator in Expanded Access Program for Delavirdine, Viracept, Sustiva, and Adefovir
- Principal Investigator in Protocol T-20/NY16391: A phase III Open Label Safety Study of T-20/Ro 29-9800 (HIV-1 fusion inhibitor) in Combination with Oral Antiretrovirals, in Patients Who are Unable to Construct a Viable Regimen
